Sowell Financial Services’s Q32 Bio QTTB Stock Holding History

Sowell Financial Services’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11	Closed	-$2K	–	2878
2020 Q3	$2K	Buy	+11	New	+$2.46K	﹤0.01%	2286

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sowell Financial Services's QTTB Position: Q4 2020 in Review

Sowell Financial Services sold out of Q32 Bio (QTTB) in Q4 2020, closing a stake of 11 shares — an estimated $2K sold.

Sowell Financial Services first reported a position in QTTB in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q4 2020.

Sowell Financial Services reported no remaining Q32 Bio position as of Q4 2020 after selling out during the quarter.
Sowell Financial Services sold 11 Q32 Bio shares in Q4 2020, an estimated $2K.
Sowell Financial Services first reported a position in Q32 Bio in Q3 2020 and held it in 1 quarter.
Sowell Financial Services's Q32 Bio position peaked at $2K in Q3 2020.
106 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2020.

Based on Sowell Financial Services's 13F filing for Q4 2020, filed 13 Jan 2021.